The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...

Automated templates on the Halo Intelligence platform will allow clinicians to rapidly identify the most effective treatment plan for each patient ...

The fastest path to breakthroughs and cures is through shared ambition, knowledge and investment, write three cancer experts at follicular lymphoma nonprofits.

UCSF grad students present research about how to track down HIV, fight brain tumors with T cells and treat brain disorders prenatally. [VIDEO] ...

“You must go get your test,” urges Knowles, mom to Beyoncé and Solange. Docs could have found her cancer earlier, she says in her new memoir, “Matriarch.” ...

Nearly three quarters of non-small cell lung cancer (NSCLC) patients with HER2 mutations experienced tumor regression when treated with zongertinib, a novel targeted therapy, according to results from ...

Most people with mismatch repair deficient (dMMR) cancers who used the checkpoint inhibitor Jemperli (dostarlimab) were able to forgo surgery and maintain their quality of life, according to study ...

Novel treatment allowed patients with colorectal cancer to successfully continue taking their cancer treatment with improved quality of life. Acne-like skin rash is a common side effect from ...

A Liquid Biopsy-based Assay Could Detect Recurrence Prior to Imaging in Patients With Resectable Colorectal Cancer An ultrasensitive circulating tumor DNA (ctDNA)-based liquid biopsy assay detected ...

From 2010 to 2020, breast cancer deaths among women ages 20-49 declined significantly across all breast cancer subtypes and racial/ethnic groups, with marked declines starting after 2016, according to ...

Patients with previously treated non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12D mutation experienced clinical benefit from the oral KRAS G12D inhibitor zoldonrasib, according to ...

CHICAGO – The American Association for Cancer Research (AACR) will honor the following cancer researchers and physician-scientists during the AACR Annual Meeting 2025, to be held April 25–30 at the ...